Since our data indicated that the T cell targeting treatment through immune checkpoint blockade, co-stimulation enhancement, and T cell growth stimulation was not sufficient to activate efficient antitumor T cell immune response, we hypothesized that non-T immune cells may be critical for IFNα-mediated tumor suppression. The gene discussed is IFNA1; the disease is neoplasm.